|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn884646529 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140726s2014 gw ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d N$T
|d E7B
|d DEBSZ
|d OCLCQ
|d OCLCF
|d RECBK
|d DG1
|d DEBBG
|d OCLCQ
|d EBLCP
|d AZK
|d COCUF
|d DG1
|d MOR
|d CCO
|d LIP
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d GWDNB
|d U3W
|d OCLCQ
|d STF
|d ICG
|d YDXCP
|d VT2
|d AU@
|d OCLCO
|d OCLCA
|d YOU
|d OCLCO
|d TKN
|d OCLCO
|d OCLCA
|d DKC
|d OCLCO
|d OCLCQ
|d UKAHL
|d OCLCQ
|d OCLCA
|d UKMGB
|d MHW
|d BRF
|d OCLCO
|d OCLCQ
|d OCLCO
|d TUHNV
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
015 |
|
|
|a GBC074137
|2 bnb
|
016 |
7 |
|
|a 1047121190
|2 DE-101
|
016 |
7 |
|
|a 1060980886
|2 DE-101
|
016 |
7 |
|
|a 106098086X
|2 DE-101
|
016 |
7 |
|
|a 016758783
|2 Uk
|
016 |
7 |
|
|a 019809008
|2 Uk
|
016 |
7 |
|
|a 1047121190
|2 GyFmDB
|
019 |
|
|
|a 889557774
|a 889642027
|a 892345090
|a 903291006
|a 961585847
|a 962644829
|a 992918072
|a 1069737146
|a 1081210568
|a 1179744301
|a 1228589761
|a 1244448252
|a 1249226807
|
020 |
|
|
|a 9783527665211
|q (electronic bk.)
|
020 |
|
|
|a 3527665218
|q (electronic bk.)
|
020 |
|
|
|a 9783527665242
|q (electronic bk.)
|
020 |
|
|
|a 3527665242
|q (electronic bk.)
|
020 |
|
|
|a 3527665234
|
020 |
|
|
|a 9783527665235
|
020 |
|
|
|z 9783527333653
|
020 |
|
|
|z 3527333657
|
020 |
|
|
|z 9783527665235
|
020 |
|
|
|z 9783527665228
|
029 |
1 |
|
|a AU@
|b 000056000714
|
029 |
1 |
|
|a CHBIS
|b 010660541
|
029 |
1 |
|
|a CHDSB
|b 006246810
|
029 |
1 |
|
|a CHNEW
|b 000943375
|
029 |
1 |
|
|a CHVBK
|b 480235988
|
029 |
1 |
|
|a DEBBG
|b BV043396993
|
029 |
1 |
|
|a DEBBG
|b BV043891685
|
029 |
1 |
|
|a DEBSZ
|b 414127714
|
029 |
1 |
|
|a DEBSZ
|b 424355337
|
029 |
1 |
|
|a DEBSZ
|b 485050757
|
029 |
1 |
|
|a GWDNB
|b 106098086X
|
029 |
1 |
|
|a GWDNB
|b 1060980886
|
029 |
1 |
|
|a UKMGB
|b 019809008
|
035 |
|
|
|a (OCoLC)884646529
|z (OCoLC)889557774
|z (OCoLC)889642027
|z (OCoLC)892345090
|z (OCoLC)903291006
|z (OCoLC)961585847
|z (OCoLC)962644829
|z (OCoLC)992918072
|z (OCoLC)1069737146
|z (OCoLC)1081210568
|z (OCoLC)1179744301
|z (OCoLC)1228589761
|z (OCoLC)1244448252
|z (OCoLC)1249226807
|
037 |
|
|
|a 9783527665235
|b Wiley
|
050 |
|
4 |
|a RS431.P38
|
060 |
|
4 |
|a 2014 I-322
|
060 |
|
4 |
|a QV 745
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a RS
|2 lcco
|
072 |
|
7 |
|a MMG.
|2 bicssc
|
072 |
|
7 |
|a PN.
|2 bicssc
|
082 |
0 |
4 |
|a 615.19
|a 615/.19
|2 22
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Ghosh, Arun K.
|
245 |
1 |
0 |
|a Structure-based design of drugs and other bioactive molecules :
|b tools and strategies /
|c Arun K. Ghosh and Sandra Gemma.
|
260 |
|
|
|a Weinheim :
|b Wiley-VCH,
|c 2014.
|
300 |
|
|
|a 1 online resource (476 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
505 |
0 |
|
|a Structure-based Design of Drugs and Other Bioactive Molecules: Tools and Strategies; Contents; Preface; 1 From Traditional Medicine to Modern Drugs: Historical Perspective of Structure-Based Drug Design; 1.1 Introduction; 1.2 Drug Discovery During 1928-1980; 1.3 The Beginning of Structure-Based Drug Design; 1.4 Conclusions; References; Part One: Concepts, Tools, Ligands, and Scaffolds for Structure-Based Design of Inhibitors; 2 Design of Inhibitors of Aspartic Acid Proteases; 2.1 Introduction; 2.2 Design of Peptidomimetic Inhibitors of Aspartic Acid Proteases.
|
505 |
8 |
|
|a 2.8.4 Design of Acyl Guanidine-Based Inhibitors2.8.5 Design of Aminopyridine-Based Inhibitors; 2.8.6 Design of Aminoimidazole- and Aminohydantoin-Based Inhibitors; 2.9 Conclusions; References; 3 Design of Serine Protease Inhibitors; 3.1 Introduction; 3.2 Catalytic Mechanism of Serine Protease; 3.3 Types of Serine Protease Inhibitors; 3.4 Halomethyl Ketone-Based Inhibitors; 3.5 Diphenyl Phosphonate-Based Inhibitors; 3.6 Trifluoromethyl Ketone Based Inhibitors; 3.6.1 Synthesis of Trifluoromethyl Ketones; 3.7 Peptidyl Boronic Acid-Based Inhibitors.
|
520 |
|
|
|a In contrast to previous texts focusing on either computational, structural or synthetic methods, this one-of-a-kind guide integrates all three skill sets for a complete picture of contemporary structure-based design. As a result, this practical book demonstrates how to develop a high-affinity ligand with drug-like properties for any given drug target for which a high-resolution structure exists. The authors, both of whom have successfully designed drug-like molecules that were later developed into marketed drugs, use numerous examples of recently developed drugs to present best practice in.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Bioactive compounds.
|
650 |
|
0 |
|a Biopolymers.
|
650 |
|
0 |
|a Ligand binding (Biochemistry)
|
650 |
|
0 |
|a Protease inhibitors.
|
650 |
|
0 |
|a Drugs
|x Structure-activity relationships.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
|
0 |
|a Molecular structure.
|
650 |
|
0 |
|a Structure-activity relationships (Biochemistry)
|
650 |
1 |
2 |
|a Drug Design
|
650 |
2 |
2 |
|a Molecular Structure
|
650 |
2 |
2 |
|a Biopolymers
|x chemistry
|
650 |
2 |
2 |
|a Protease Inhibitors
|x chemistry
|
650 |
2 |
2 |
|a Structure-Activity Relationship
|
650 |
|
2 |
|a Biopolymers
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Composés bioactifs.
|
650 |
|
6 |
|a Biopolymères.
|
650 |
|
6 |
|a Ligands (Biochimie)
|x Fixation.
|
650 |
|
6 |
|a Médicaments
|x Relations structure-activité.
|
650 |
|
6 |
|a Médicaments
|x Conception.
|
650 |
|
6 |
|a Structure moléculaire.
|
650 |
|
6 |
|a Relations structure-activité (Biochimie)
|
650 |
|
7 |
|a molecular structure.
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Structure-activity relationships (Biochemistry)
|2 fast
|
650 |
|
7 |
|a Molecular structure
|2 fast
|
650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
650 |
|
7 |
|a Bioactive compounds
|2 fast
|
650 |
|
7 |
|a Biopolymers
|2 fast
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Drugs
|x Structure-activity relationships
|2 fast
|
650 |
|
7 |
|a Ligand binding (Biochemistry)
|2 fast
|
650 |
|
7 |
|a Protease inhibitors
|2 fast
|
700 |
1 |
|
|a Gemma, Sandra.
|
758 |
|
|
|i has work:
|a Structure-based design of drugs and other bioactive molecules (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGGt8GJ88mVmGhpqKcpQdP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Ghosh, Arun K.
|t Structure-based Design of Drugs and Other Bioactive Molecules.
|d Hoboken : Wiley, 2014
|z 9783527333653
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1744759
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26885620
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26885670
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1744759
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4044465
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10901883
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 815413
|
938 |
|
|
|a Recorded Books, LLC
|b RECE
|n rbeEB00596189
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11997958
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11072872
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12679537
|
994 |
|
|
|a 92
|b IZTAP
|